Khatchadourian, C.; Sisliyan, C.; Nguyen, K.; Poladian, N.; Tian, Q.; Tamjidi, F.; Luong, B.; Singh, M.; Robison, J.; Venketaraman, V.
Hyperlipidemia and Obesity’s Role in Immune Dysregulation Underlying the Severity of COVID-19 Infection. Clin. Pract. 2021, 11, 694-707.
https://doi.org/10.3390/clinpract11040085
AMA Style
Khatchadourian C, Sisliyan C, Nguyen K, Poladian N, Tian Q, Tamjidi F, Luong B, Singh M, Robison J, Venketaraman V.
Hyperlipidemia and Obesity’s Role in Immune Dysregulation Underlying the Severity of COVID-19 Infection. Clinics and Practice. 2021; 11(4):694-707.
https://doi.org/10.3390/clinpract11040085
Chicago/Turabian Style
Khatchadourian, Christopher, Christina Sisliyan, Kevin Nguyen, Nicole Poladian, Qi Tian, Faraaz Tamjidi, Bao Luong, Manpreet Singh, Jeremiah Robison, and Vishwanath Venketaraman.
2021. "Hyperlipidemia and Obesity’s Role in Immune Dysregulation Underlying the Severity of COVID-19 Infection" Clinics and Practice 11, no. 4: 694-707.
https://doi.org/10.3390/clinpract11040085
APA Style
Khatchadourian, C., Sisliyan, C., Nguyen, K., Poladian, N., Tian, Q., Tamjidi, F., Luong, B., Singh, M., Robison, J., & Venketaraman, V.
(2021). Hyperlipidemia and Obesity’s Role in Immune Dysregulation Underlying the Severity of COVID-19 Infection. Clinics and Practice, 11(4), 694-707.
https://doi.org/10.3390/clinpract11040085
